Adrian Kielhorn

Senior Director, Global Head HEOR Neurology Alexion Pharmaceuticals

Adrian has spent most of his career working for pharmaceutical companies in health economics and outcomes research (HEOR) roles. He broadened his experience working in market access, strategic pricing, marketing, and sales roles. As a leader, he instills in groups, teams, and organizations a passion for generating high-quality and patient-relevant value evidence that directly impacts market access. As a value evidence architect in rare diseases, he pioneers new approaches to measure patient-centric value of pharmaceutical interventions. His interest in health equity has led him to develop diversity measures and identify barriers to improve access and treatments in rare diseases. Adrian believes in the partnership of men and women in all fields of endeavor and a member of EBBF, an organization dedicated to building ethical businesses. He is the author of the Market Access Guide, the Health Economics Handbook and has been a co-author in over 25 peer-reviewed manuscripts.